ArticleFrontiers in pharmacology2026
Albumin overload reduces CFTR and V-ATPase expression and impairs albumin endocytosis and degradation in a renal proximal tubule cell line.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Albuminuria is a hallmark of kidney disease progression and is associated with impaired glomerular and proximal tubule albumin handling. Efficient receptor-mediated endocytosis and intracellular protein processing in proximal tubule cells require endosomal acidification, a process that depends on multiple transporters, including Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), and its functional interaction with vacuolar H Methods: LLC-PK1 were exposed to low (0.1 mg/mL) or high (20 mg/mL; overload) concentrations of Bovine Serum Albumin (BSA) for 24 or 48 h. CFTR and V-ATPase protein expression were evaluated by Western blotting. Albumin uptake and degradation were assessed using FITC-conjugated BSA (BSA-FITC). CFTR cellular staining was analyzed by confocal immunofluorescence microscopy. Results: Exposure to 20 mg/mL BSA significantly reduced CFTR expression after both 24 and 48 h, whereas no effects were observed after incubation with a low albumin concentration. V-ATPase expression was significantly reduced only after 48 h of albumin overload. High albumin concentrations also decreased BSA-FITC uptake, with a greater inhibitory effect observed after 48 h of treatment. Furthermore, albumin-overloaded cells exhibited impaired intracellular degradation of endocytosed BSA-FITC, as demonstrated by sustained fluorescence intensity and an increased area under the degradation curve. Confocal microscopy revealed reduced CFTR fluorescence intensity under albumin overload conditions, but no evident alterations in its overall subcellular distribution. Conclusion: BSA overload coordinately downregulates CFTR and V-ATPase expression and is associated with impaired albumin endocytosis and degradation in proximal tubule cells. These findings reveal a novel association between albumin overload and downregulation of CFTR and V-ATPase proteins in proximal tubule cells. Although the present data are correlative and do not establish a direct causal link between CFTR downregulation and the observed functional defects, they suggest that CFTR/V-ATPase dysregulation may contribute to defective albumin handling under proteinuric conditions and provide a rationale for future mechanistic investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.